JAZZ PHARMACEUTICALS, INC
Federal contract awards won by JAZZ PHARMACEUTICALS, INC (UEI H9AXCNRA5NE6), 2021–2026 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
11
awards
1
expiring in 12 months
1
agency
Agencies buying from JAZZ PHARMACEUTICALS, INC
What JAZZ PHARMACEUTICALS, INC has provided
Awards
XYWAV 500MG/ML ORAL SOLN
Department of Veterans Affairs · $397,859 · Feb 1, 2026
XYWAV 500MG/ML ORAL SOLUTION, AND XYREM 500MG/ML ORAL SOLUTION
Department of Veterans Affairs · $456,131 · Oct 1, 2025
BULK ORDER XYWAV
Department of Veterans Affairs · $681,888 · Jun 1, 2025
BULK PHARMACY XYWAV
Department of Veterans Affairs · $634,238 · Dec 1, 2024
XYWAV BULK
Department of Veterans Affairs · $265,971 · Oct 1, 2024
XYWAV 500MG/ML ORAL SOLUTION (SOLN).
Department of Veterans Affairs · $310,193 · Oct 1, 2024
BPA FOR XYREM, XYWAV
Department of Veterans Affairs · No current value reported · Aug 16, 2024
XYWAV BULK ORDER
Department of Veterans Affairs · $463,744 · Jun 1, 2024
XYWAV
Department of Veterans Affairs · $682,560 · Nov 1, 2023
SODIUM OXYBATE (XYREM) AND CALCIUM/MAGNESIUM/POTASSIUM/SODIUM OXYBATE (XYWAV)
Department of Veterans Affairs · $963,401 · Nov 1, 2022
EO14042 SODIUM OXYBATE (XYREM) 500MG/ML SOLN & CALCIUM/MAGNESIUM/POTASSIUM/SODIUM OXYBATE
Department of Veterans Affairs · $767,851 · Nov 1, 2021